Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus
{{output}}
Objective: To study self-administration and pharmacokinetics (PK) of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE). Methods: ... ...
